[Pathophysiology and therapy of castration-resistant prostate cancer].
Merseburger, A S
[Pathophysiology and therapy of castration-resistant prostate cancer]. [electronic resource] - Der Urologe. Ausg. A Feb 2013 - 219-25 p. digital
Publication Type: Journal Article; Review
1433-0563
10.1007/s00120-012-3054-8 doi
Androgen Antagonists--adverse effects
Androstenes
Androstenols--adverse effects
Antineoplastic Agents, Hormonal--adverse effects
Benzamides
Biomarkers, Tumor--blood
Disease Progression
Drug Resistance, Neoplasm
Humans
Imidazoles--adverse effects
Male
Naphthalenes--adverse effects
Nitriles
Orchiectomy
Phenylthiohydantoin--adverse effects
Prostate--drug effects
Prostate-Specific Antigen--blood
Prostatic Neoplasms--drug therapy
[Pathophysiology and therapy of castration-resistant prostate cancer]. [electronic resource] - Der Urologe. Ausg. A Feb 2013 - 219-25 p. digital
Publication Type: Journal Article; Review
1433-0563
10.1007/s00120-012-3054-8 doi
Androgen Antagonists--adverse effects
Androstenes
Androstenols--adverse effects
Antineoplastic Agents, Hormonal--adverse effects
Benzamides
Biomarkers, Tumor--blood
Disease Progression
Drug Resistance, Neoplasm
Humans
Imidazoles--adverse effects
Male
Naphthalenes--adverse effects
Nitriles
Orchiectomy
Phenylthiohydantoin--adverse effects
Prostate--drug effects
Prostate-Specific Antigen--blood
Prostatic Neoplasms--drug therapy